Lantheus Holdings, Inc. engages in the provision of diagnostic imaging and nuclear medicine products. The firm develops products that help healthcare professionals in patient management and outcomes and assists clinicians with the detection of cardiovascular disease. It operates through the U.S. and International geographical segments. The U.S. segment produces and markets products, radiopharmacies, PMFs, integrated delivery networks, hospitals, clinics, and group practices throughout the United States. The International segment offers direct distribution in Canada and third-party distribution relationships in Europe, Canada, Australia, Asia-Pacific, Central America, and South America. The company was founded in 1956 and is headquartered in Bedford, MA.
Market Cap
$5.52B
P/E Ratio
13.2
1Y Stock Return
16.60%
1Y Revenue Growth
24.15%
Dividend Yield
0.00%
Price to Book
4.8
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
LLYVK | 0.04% | $6.24B | +94.65% | 0.00% |
ACGL | -0.04% | $36.00B | +16.84% | 0.00% |
WMT | 0.05% | $696.11B | +66.69% | 1.38% |
MSI | 0.06% | $81.46B | +52.34% | 0.80% |
IMNN | 0.08% | $10.02M | -22.89% | 0.00% |
GOOGL | 0.08% | $2.18T | +30.04% | 0.23% |
AQB | 0.09% | $3.78M | -37.77% | 0.00% |
HBAN | -0.09% | $25.48B | +60.92% | 3.53% |
TPG | -0.09% | $6.62B | +96.76% | 2.43% |
LAKE | -0.10% | $159.62M | +47.81% | 0.56% |
AXP | 0.15% | $201.15B | +75.95% | 0.94% |
JNPR | 0.15% | $11.61B | +30.55% | 2.49% |
CSTE | -0.16% | $134.01M | +2.92% | 0.00% |
RVP | 0.17% | $17.51M | -46.82% | 0.00% |
LU | -0.18% | $2.01B | -33.75% | 0.00% |
ARMK | 0.18% | $9.93B | +35.19% | 1.01% |
LSPD | 0.19% | $2.68B | +7.42% | 0.00% |
CBOE | -0.25% | $21.46B | +15.84% | 1.11% |
AJG | 0.26% | $64.17B | +17.51% | 0.80% |
RRC | -0.27% | $8.29B | +4.16% | 0.92% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
X | -26.72% | $8.76B | +13.32% | 0.51% |
LZ | -22.14% | $1.30B | -33.57% | 0.00% |
FUN | -21.04% | $4.60B | -16.51% | 0.00% |
ZIMV | -20.52% | $363.48M | +47.32% | 0.00% |
MA | -18.86% | $476.78B | +27.02% | 0.51% |
GEO | -18.03% | $3.97B | +204.07% | 0.00% |
DRVN | -17.71% | $2.68B | +26.39% | 0.00% |
COR | -14.89% | $47.48B | +21.20% | 0.86% |
CXW | -14.71% | $2.43B | +62.08% | 0.00% |
VSTS | -14.51% | $1.76B | -18.18% | 1.04% |
HUBS | -14.36% | $35.23B | +44.73% | 0.00% |
HQY | -12.55% | $8.97B | +52.15% | 0.00% |
DFS | -12.44% | $43.31B | +100.72% | 1.62% |
CQP | -11.71% | $25.90B | -6.77% | 5.96% |
WHLM | -11.36% | $17.64M | -29.34% | 0.00% |
V | -11.19% | $595.29B | +23.64% | 0.69% |
GLP | -11.14% | $1.77B | +51.33% | 5.50% |
UFCS | -11.07% | $696.15M | +35.19% | 2.34% |
TCTM | -10.98% | $8.10M | -42.99% | 0.00% |
DASH | -10.69% | $73.18B | +86.24% | 0.00% |
Yahoo
The stock of radiopharmaceutical specialist Lantheus Holdings (NASDAQ: LNTH) was a standout in the healthcare sector on Hump Day. The company saw its share price improve by almost 9% at market close, thanks to news of a shareholder-pleasing move. Well before market open, Lantheus announced the launch of a $250 million share repurchase program.
Finnhub
Lantheus Holdings, Inc. , the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, announces that its...
Yahoo
BEDFORD, Mass., Nov. 20, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (Lantheus or the Company) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, announces that its board of directors has authorized a program to repurchase up to $250 million of its common stock during the next twelve months. “With our strong financial position and the Board’s commitment to shareholder value, t
Yahoo
BEDFORD, Mass., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, today announced Bob Marshall, Chief Financial Officer and Treasurer, will present at the Jefferies London Healthcare Conference at 1:00 p.m. GMT (8 a.m. EST) on Wednesday, November 20. To access a live webcast of the presentation, please visit th
Yahoo
Despite announcing strong earnings, Lantheus Holdings, Inc.'s ( NASDAQ:LNTH ) stock was sluggish. Our analysis...
Yahoo
BEDFORD, Mass., Nov. 11, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, notes that the Centers for Medicare & Medicaid Services (CMS) recently posted updated payment rates in Addendum B related to the final rule for the calendar year 2025 Medicare Hospital Outpatient Prospective Payment System (OPPS)
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CMBM | 35.93% | $30.22M | -75.23% | 0.00% |
SEI | 35.52% | $616.12M | +133.06% | 2.39% |
GPCR | 33.21% | $1.88B | -36.14% | 0.00% |
OCUL | 32.92% | $1.40B | +307.31% | 0.00% |
SEG | 32.68% | $319.72M | +12.41% | 0.00% |
VAC | 32.41% | $3.13B | +16.15% | 3.39% |
MFA | 31.97% | $1.13B | +5.15% | 12.73% |
PPBI | 31.89% | $2.67B | +20.00% | 4.75% |
APAM | 31.39% | $3.25B | +26.70% | 6.08% |
KMT | 30.97% | $2.17B | +21.08% | 2.88% |
PATK | 30.86% | $2.90B | +54.53% | 1.67% |
MTH | 30.65% | $6.45B | +26.52% | 1.42% |
PCT | 30.39% | $1.93B | +208.73% | 0.00% |
NTB | 30.39% | - | - | 4.69% |
TRMK | 30.36% | $2.32B | +69.09% | 2.44% |
W | 30.14% | $5.11B | -15.44% | 0.00% |
IIPR | 30.14% | $3.01B | +33.85% | 7.00% |
ONB | 30.01% | $6.69B | +43.24% | 2.68% |
GT | 29.95% | $2.60B | -34.81% | 0.00% |
WERN | 29.85% | $2.43B | +0.51% | 1.43% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
GRPM | 34.47% | $582.50M | 0.35% |
GSSC | 32.42% | $529.86M | 0.2% |
VTWO | 32.39% | $12.38B | 0.1% |
SLYV | 32.33% | $4.16B | 0.15% |
IWN | 32.31% | $13.17B | 0.24% |
IJS | 32.21% | $7.37B | 0.18% |
IWM | 32.18% | $75.73B | 0.19% |
JMEE | 32.16% | $1.51B | 0.24% |
IWO | 32.14% | $12.56B | 0.24% |
NUSC | 32.14% | $1.27B | 0.31% |
ESML | 32.02% | $1.90B | 0.17% |
FYX | 32.01% | $959.00M | 0.6% |
VIOV | 31.96% | $1.44B | 0.15% |
PSC | 31.70% | $702.17M | 0.38% |
IJR | 31.54% | $90.05B | 0.06% |
SPMD | 31.42% | $12.03B | 0.03% |
PRFZ | 31.40% | $2.65B | 0.39% |
XJH | 31.29% | $248.84M | 0.12% |
IVOO | 31.17% | $2.38B | 0.1% |
MDY | 31.15% | $24.14B | 0.24% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
WEAT | -0.12% | $120.27M | 0.28% |
PGHY | -0.24% | $141.95M | 0.35% |
FLBL | 0.25% | $645.58M | 0.45% |
TAIL | 0.42% | $67.98M | 0.59% |
FTGC | 0.42% | $2.17B | 1.02% |
UNG | -0.49% | $908.80M | 1.06% |
FLRT | 0.55% | $401.26M | 0.6% |
CTA | -0.57% | $350.27M | 0.78% |
HIGH | -0.60% | $302.78M | 0.51% |
XBIL | 0.62% | $637.70M | 0.15% |
UCON | -0.66% | $3.19B | 0.85% |
SHYD | 0.67% | $311.50M | 0.35% |
FMF | -0.82% | $244.61M | 0.95% |
IBTE | 0.83% | $1.70B | 0.07% |
USTB | 0.91% | $797.28M | 0.35% |
CSHI | -0.98% | $482.85M | 0.38% |
AGZD | 1.14% | $142.76M | 0.23% |
SGOV | 1.42% | $27.53B | 0.09% |
IBMM | 1.50% | $391.28M | 0.18% |
CGSM | 1.58% | $514.53M | 0.25% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
USDU | -24.66% | $201.97M | 0.5% |
UUP | -23.54% | $309.25M | 0.77% |
BTAL | -19.85% | $388.04M | 1.43% |
EQLS | -16.75% | $76.08M | 1% |
KCCA | -9.52% | $220.51M | 0.87% |
QQA | -9.41% | $135.01M | 0% |
SOYB | -9.17% | $27.32M | 0.22% |
VCAR | -7.68% | $9.00M | 1.2% |
VIXY | -7.57% | $195.31M | 0.85% |
TBIL | -7.52% | $4.38B | 0.15% |
SEIX | -7.42% | $268.81M | 0.62% |
BSCO | -6.33% | $2.35B | 0.1% |
DBA | -6.13% | $755.88M | 0.93% |
JUCY | -5.93% | $324.29M | 0.6% |
MINT | -5.10% | $11.62B | 0.35% |
HYMB | -4.86% | $2.81B | 0.35% |
KRBN | -3.47% | $242.47M | 0.85% |
FBY | -3.29% | $127.69M | 0.99% |
PULS | -3.14% | $8.78B | 0.15% |
ULST | -3.12% | $535.47M | 0.2% |
Current Value
$82.731 Year Return
Current Value
$82.731 Year Return